Filter
4484
Filtered Results: 4484
Text search:
drug
strategy
Featured
Recommendations
389
New Publications
1253
Language
Document type
No document type
2714
Studies & Reports
734
Guidelines
526
Manuals
188
Strategic & Response Plan
169
Fact sheets
60
Training Material
50
Situation Updates
20
Infographics
13
Resource Platforms
6
Brochures
2
Dashboards/Maps
1
App
1
Countries / Regions
India
225
Global
164
Kenya
152
South Africa
115
Uganda
113
Ethiopia
106
Western and Central Europe
100
Nigeria
94
Nepal
86
Liberia
80
Zambia
78
Tanzania
77
Sierra Leone
76
Malawi
74
Myanmar / Burma
72
Latin America and the Carribbean
70
Bangladesh
63
Africa
62
Ghana
58
Rwanda
53
Eastern Europe
49
Namibia
44
Ukraine
42
Philippines
41
Indonesia
40
Asia
39
Zimbabwe
36
Cambodia
36
South–East Asia Region
34
Lesotho
31
Botswana
25
Russia
24
Syria
22
Congo, Democratic Republic of
20
Colombia
18
Mozambique
18
Senegal
17
Eswatini/ Swaziland
16
Burkina Faso
15
Brazil
15
East and Southern Africa
14
West and Central Africa
13
South Sudan
13
Middle East and North Africa
12
Eastern Europe and Central Asia
12
Cameroon
11
Albania
11
Tajikistan
10
Thailand
10
Venezuela
10
Pakistan
10
Guinea
9
USA
9
Haiti
9
Sudan
9
Georgia
9
Germany
8
Peru
7
Western Pacific Region
7
Vietnam
7
Benin
6
Laos
6
Afghanistan
6
Argentina
6
China
5
North America
5
Sri Lanka
5
Iraq
5
North Macedonia
4
Mexico
4
Turkey
4
Iran
4
Jordan
4
Lebanon
4
Moldova
4
Yemen
4
Central African Republic
4
Timor Leste/ East Timor
3
El Salvador
3
Armenia
3
Paraguay
3
Jamaica
3
Bolivia
3
Bhutan
3
Somalia
3
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
United Kingdom
2
Portugal
2
Spain
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Switzerland
1
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Fiji
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1801
Clinical Guidelines
366
Public Health
236
Women & Child Health
149
Key Resources
130
Capacity Building
49
Pharmacy & Technologies
44
Annual Report MEDBOX
1
Toolboxes
HIV
555
TB
458
Mental Health
338
AMR
239
NTDs
205
COVID-19
168
Pharmacy
109
NCDs
99
Rapid Response
81
Caregiver
74
Ebola & Marburg
64
Planetary Health
63
Malaria
63
Conflict
52
Global Health Education
48
Disability
47
Refugee
45
Health Financing Toolbox
45
Polio
22
Natural Hazards
17
Cholera
15
Specific Hazards
14
Zika
10
Social Ethics
9
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
Anti-stigma programs have exploded in the United States as well as across
the world in the past decade. Now needed is a more strategic approach to stigma
change, consideration of evaluation strategies that demonstrate its effectiveness.
Accessed on 31.03.2023
COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community engagement strategy. A situational analysis conducted i...
The education sector forms an important part of the child protection response in refugee settings, and UNHCR’s Education Strategy (2012-16) reflects a focus on refugee education as a core component of UNHCR’s protection mandate. The right to education for all children also forms part of the Unit...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
These guidelines for the prevention and management of cardiovascular diseases are a critical ingredient for streamlining care across the entire health services provision continuum. They are a strategic component in achieving universal health coverage, securing affordable heal...
The objective of the evaluation is to understand whether the CHW program has achieved its intended objectives, thus contributing to the overarching objectives defined in the HSSP III of improving the health status of the population by “Ensuring universal accessibility of quality health services fo...
3rd edition. In 2001, Uganda adapted the Integrated Disease Surveillance and Response (IDSR) developed by World Health Organization (WHO) for member states in African region. The Ministry of Health has been implementing the IDSR strategy since then with success across the country. This strategy prov...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
Joint actions by the Global Fund and UNAIDS are guided by a strong alignment of strategies, goals and targets. UNAIDS has worked with all stakeholders to set a common agenda and targets within the Global AIDS Strategy 2021–2026, and the United Nations General Assembly confirmed this strategy and i...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
The report aims to help policy-makers and programme managers identify the areas that need attention and to work towards effective implementation and enforcement of policies and legislations. The need for alcohol policy-specific infrastructures to support the alcohol policy process, including designa...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
